Nilutamide

Description: Nilutamide (RU23908), an antineoplastic hormonal agent, is mainly used in the treatment of prostate Y. Nilutamide is a pure, nonsteroidal anti-androgen with affinity for androgen receptors, but not for estrogen, progestogen, or glucocorticoid receptors. Therefore, Nilutamide can block the action of androgens of testicular and adrenal origin that stimulate the growth of malignant and normal prostatic tissue. Prostate Y is mainly androgen-dependent and can be treat with chemical castration or surgical. So far, antiandrogen monotherapy has not consistently been certified to be equivalent to castration. Target: Androgen Receptor. Smiles: O=C1N(C(=O)NC1(C)C)C2=CC(C(F)(F)F)=C(N(=O)=O)C=C2. References: Raynaud JP. Am J Clin Oncol. 1988,11 Suppl 2:S132-47.